Cancer Family
Malignant Head and Neck Neoplasm
CI-CAN-00000236Explore in graph →
1,432 active trials17 approved drugs142 evidence items
Loading cancer entity…
Loading cancer entity…
Cancer Family
CI-CAN-00000236Explore in graph →
Clinical trials
5,449 studies whose conditions map to this entity or one of its descendants. Status and phase are as posted on ClinicalTrials.gov. 50 studies per page.
Computedformula ci-trial-intel-v1 · interventional studies · entity + NCIt descendants · hover a figure for its formulaCompare cancersTerminated studies (629)
| NCT | Title | Status | Phase | Enrollment (n) | Sponsor | Countries | Last update | Source |
|---|---|---|---|---|---|---|---|---|
| NCT00096512 | S0420, Sorafenib in Treating Patients With Recurrent or Metastatic Head and Neck Cancer | completed | Phase 2 | 40 | National Cancer Institute (NCI)NIH | 1 | Feb 28, 2013 | clinicaltrials |
| NCT00126607 | Trastuzumab in Treating Patients With Metastatic or Recurrent Salivary Gland Cancer | terminated | Phase 2 | 35 | National Cancer Institute (NCI)NIH | 1 | Feb 28, 2013 | clinicaltrials |
| NCT00033618 |
| Ixabepilone in Treating Patients With Metastatic or Recurrent Squamous Cell Cancer of the Head and Neck |
| completed |
| Phase 2 |
| 144 |
| National Cancer Institute (NCI)NIH |
| 1 |
| Feb 27, 2013 |
| clinicaltrials |
| NCT00215605 | Study of XL184 (Cabozantinib) in Adults With Advanced Malignancies | completed | Phase 1 | 85 | ExelixisINDUSTRY | 1 | Feb 27, 2013 | clinicaltrials |
| NCT01237704 | Dysphagia Rehabilitation for Nasopharyngeal Carcinoma Patients Post Radiotherapy | unknown | N/A | 160 | Chinese University of Hong KongOTHER | 1 | Feb 26, 2013 | clinicaltrials |
| NCT00004604 | Biological Therapy in Treating Patients With Metastatic Cancer | completed | Phase 1 | 24 | Duke UniversityOTHER | 1 | Feb 22, 2013 | clinicaltrials |
| NCT00392704 | Treatment of Head & Neck Cancer With Chemotherapy and Radiation | completed | Phase 2 | 60 | SCRI Development Innovations, LLCOTHER | 1 | Feb 22, 2013 | clinicaltrials |
| NCT01058408 | RAD001 With Weekly Cisplatin and Radiation Therapy in Patients With Locally Advanced Head and Neck Cancer | terminated | Phase 1 | 3 | Dana-Farber Cancer InstituteOTHER | 1 | Feb 22, 2013 | clinicaltrials |
| NCT00686465 | Positron Emission Tomography/Computed Tomography (PET/CT) for the Diagnosis of Recurrent Cancer: a Feasibility Study(PETREC) | completed | N/A | 101 | Ontario Clinical Oncology Group (OCOG)OTHER | 1 | Feb 18, 2013 | clinicaltrials |
| NCT01379872 | Assessment of New Radiation Oncology Technologies and Treatments(ANROTAT) | completed | — | 138 | Trans Tasman Radiation Oncology GroupOTHER | 1 | Feb 13, 2013 | clinicaltrials |
| NCT00024089 | Gefitinib in Treating Patients With Recurrent and/or Metastatic Head and Neck Cancer | completed | Phase 2 | 60 | National Cancer Institute (NCI)NIH | 1 | Feb 11, 2013 | clinicaltrials |
| NCT00057850 | BMS-247550 Plus Cisplatin in Treating Patients With Metastatic or Recurrent Head and Neck Cancer | completed | Phase 1 / Phase 2 | 27 | National Cancer Institute (NCI)NIH | 1 | Feb 11, 2013 | clinicaltrials |
| NCT00003850 | Thalidomide in Treating Patients With Recurrent or Metastatic Head and Neck Cancer | completed | Phase 2 | 47 | National Cancer Institute (NCI)NIH | 1 | Feb 8, 2013 | clinicaltrials |
| NCT00023959 | Bevacizumab, Fluorouracil, and Hydroxyurea Plus Radiation Therapy in Treating Patients With Advanced Head and Neck Cancer | completed | Phase 1 | 39 | National Cancer Institute (NCI)NIH | 1 | Feb 7, 2013 | clinicaltrials |
| NCT01384890 | Feasibility of VMAT and CBCT for Head and Neck Carcinomas | completed | Phase 1 | 20 | British Columbia Cancer AgencyOTHER | 1 | Feb 6, 2013 | clinicaltrials |
| NCT00002964 | Porfimer Sodium in Diagnosing Patients With Head and Neck Cancer | completed | Phase 2 | — | Roswell Park Cancer InstituteOTHER | 1 | Feb 5, 2013 | clinicaltrials |
| NCT00007982 | Chemotherapy Plus Peripheral Stem Cell Transplant in Treating Patients With Central Nervous System Cancer | completed | Phase 2 | 30 | Herbert Irving Comprehensive Cancer CenterOTHER | 1 | Feb 4, 2013 | clinicaltrials |
| NCT00251316 | Effect of Lithium Carbonate on Low-Dose Radioiodine Therapy in Early Thyroid Cancer | completed | Phase 2 | 34 | National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)NIH | 1 | Feb 4, 2013 | clinicaltrials |
| NCT01783158 | Chromoendoscopy to Detect Early Synchronous Second Primary Esophageal Carcinoma(HNSCC) | completed | — | 132 | University Hospital OstravaOTHER | 1 | Feb 4, 2013 | clinicaltrials |
| NCT01781767 | Changes in Metabolic Status in Patients With Total Thyroidectomy(Thyroid cancer) | unknown | — | 50 | Tel-Aviv Sourasky Medical CenterOTHER_GOV | 1 | Feb 1, 2013 | clinicaltrials |
| NCT00003569 | Dimesna in Treating Patients With Solid Tumors Who Are Undergoing Treatment With Cisplatin and Paclitaxel | completed | — | 2 | Roswell Park Cancer InstituteOTHER | 1 | Jan 31, 2013 | clinicaltrials |
| NCT00005035 | Oxaliplatin in Treating Patients With Advanced Head and Neck Cancer | completed | Phase 2 | — | Ohio State University Comprehensive Cancer CenterOTHER | 1 | Jan 31, 2013 | clinicaltrials |
| NCT00280891 | Review of Palliative Radiotherapy in the Management of Advanced Head and Neck Cancer | completed | — | 100 | Alberta Health servicesOTHER | 1 | Jan 28, 2013 | clinicaltrials |
| NCT00028496 | Vaccine Therapy With or Without Sargramostim in Treating Patients With Advanced or Metastatic Cancer | completed | Phase 1 | 48 | National Cancer Institute (NCI)NIH | 1 | Jan 25, 2013 | clinicaltrials |
| NCT00033449 | Gefitinib and Radiation Therapy With or Without Cisplatin in Treating Patients With Stage III or Stage IV Head and Neck Cancer | terminated | Phase 1 | 30 | National Cancer Institute (NCI)NIH | 1 | Jan 25, 2013 | clinicaltrials |
| NCT00305734 | Bortezomib and Gemcitabine in Treating Patients With Recurrent or Metastatic Nasopharyngeal Cancer | completed | Phase 2 | 50 | National Cancer Institute (NCI)NIH | 1 | Jan 25, 2013 | clinicaltrials |
| NCT00077428 | Bortezomib Followed by the Addition of Doxorubicin at Disease Progression in Treating Patients With Locally Advanced, Recurrent, or Metastatic Adenoid Cystic Carcinoma (Cancer) of the Head and Neck | completed | Phase 2 | 37 | National Cancer Institute (NCI)NIH | 1 | Jan 24, 2013 | clinicaltrials |
| NCT00081211 | Intratumoral PV701 in Treating Patients With Advanced or Recurrent Unresectable Squamous Cell Carcinoma of the Head and Neck | terminated | Phase 1 | 30 | National Cancer Institute (NCI)NIH | 1 | Jan 24, 2013 | clinicaltrials |
| NCT00064103 | Gene Therapy in Preventing Cancer in Patients With Premalignant Carcinoma of the Oral Cavity or Pharynx | completed | Phase 1 / Phase 2 | 51 | National Cancer Institute (NCI)NIH | 1 | Jan 23, 2013 | clinicaltrials |
| NCT00140556 | Angiogenic and EGFR Blockade With Curative Chemoradiation for Advanced Head and Neck Cancer | completed | Early Phase 1 | 28 | David M. Brizel, MDOTHER | 1 | Jan 18, 2013 | clinicaltrials |
| NCT00828516 | Using Traditional Acupuncture in the Management of Cancer Treatment Related Lymphoedema(AMWELL-SL) | completed | N/A | 56 | East and North Hertfordshire NHS TrustOTHER_GOV | 1 | Jan 17, 2013 | clinicaltrials |
| NCT00014404 | Celecoxib in Treating Patients With Precancerous Lesions of the Mouth | completed | Phase 2 | — | Memorial Sloan Kettering Cancer CenterOTHER | 1 | Jan 16, 2013 | clinicaltrials |
| NCT00030498 | Erlotinib in Treating Patients With Solid Tumors and Liver or Kidney Dysfunction | completed | Phase 1 | 75 | National Cancer Institute (NCI)NIH | 1 | Jan 16, 2013 | clinicaltrials |
| NCT01683110 | Expanded Access of Cabozantinib in Medullary Thyroid Cancer | approved for marketing | — | — | ExelixisINDUSTRY | 1 | Jan 16, 2013 | clinicaltrials |
| NCT00068497 | Gefitinib in Treating Patients With Metastatic or Unresectable Head and Neck Cancer or Non-Small Cell Lung Cancer | completed | N/A | 40 | National Cancer Institute (NCI)NIH | 1 | Jan 14, 2013 | clinicaltrials |
| NCT00604318 | Quality of Life, Recombinant TSH (Thyrogen) and Thyroid Cancer | completed | Phase 4 | 56 | Copenhagen University Hospital at HerlevOTHER | 1 | Jan 10, 2013 | clinicaltrials |
| NCT00063895 | Erlotinib in Treating Patients With Advanced Non-Small Cell Lung Cancer, Ovarian Cancer, or Squamous Cell Carcinoma of the Head and Neck | completed | Phase 1 / Phase 2 | 80 | National Cancer Institute (NCI)NIH | 1 | Jan 9, 2013 | clinicaltrials |
| NCT01487057 | Lipid Metabolic Status in Thyroid Carcinoma(LITCA) | completed | — | 52 | Prof. Dr. I. Chiricuta Institute of OncologyOTHER | 1 | Dec 27, 2012 | clinicaltrials |
| NCT01015664 | Combination of Cisplatin, Cetuximab and Temsirolimus in Recurrent or Metastatic Squamous Cell Carcinoma of the Head and Neck | terminated | Phase 1 / Phase 2 | 11 | University of Tennessee Cancer InstituteOTHER | 1 | Dec 17, 2012 | clinicaltrials |
| NCT01506427 | A Study of [F-18]HX4 (PET Imaging)Evaluated in Head and Neck Cancer Patients | withdrawn | Phase 1 / Phase 2 | 0 | Siemens Molecular ImagingINDUSTRY | 1 | Dec 17, 2012 | clinicaltrials |
| NCT00003193 | Paclitaxel and Radiation Therapy Plus Chemoprotection With Amifostine in Treating Patients With Stage III or Stage IV Head and Neck Cancer | completed | Phase 1 / Phase 2 | 37 | Massachusetts General HospitalOTHER | 1 | Dec 6, 2012 | clinicaltrials |
| NCT00527982 | Celecoxib as Adjuvant Biologic Therapy in Patients With Head and Neck and Lung Cancer | terminated | Phase 2 | 1 | M.D. Anderson Cancer CenterOTHER | 1 | Dec 6, 2012 | clinicaltrials |
| NCT01565486 | Safety and Efficacy Study of Ultrasonic Coagulation Device and Bipolar Energy Sealing System(UCBEST) | unknown | N/A | 304 | Seoul St. Mary's HospitalOTHER | 1 | Dec 5, 2012 | clinicaltrials |
| NCT01341197 | Fecal Screening Assay for Taiwanese Population | completed | — | 3,172 | National Taiwan University HospitalOTHER | 1 | Dec 3, 2012 | clinicaltrials |
| NCT01415986 | Interstitial Photodynamic Therapy (PDT) With Temoporfin for Advanced Head and Neck Cancers | terminated | Phase 2 | 1 | University of ArkansasOTHER | 1 | Dec 3, 2012 | clinicaltrials |
| NCT01739634 | The Efficacy of CASAD in Patients With Diarrhea Related to Medullary Thyroid Cancer | unknown | Phase 1 / Phase 2 | 10 | Salient Pharmaceuticals IncorporatedINDUSTRY | 1 | Dec 3, 2012 | clinicaltrials |
| NCT00899054 | Safety and Efficacy Study of P276-00 in Combination With Radiation in Subjects With Advanced Head and Neck Cancer(SPARK) | completed | Phase 1 / Phase 2 | 23 | Piramal Enterprises LimitedINDUSTRY | 1 | Nov 22, 2012 | clinicaltrials |
| NCT00427102 | MRX, Radiation, and Chemotherapy for Patients With Resected Squamous Cell Carcinoma of the Head and Neck | terminated | Phase 1 | — | Sidney Kimmel Comprehensive Cancer Center at Johns HopkinsOTHER | 0 | Nov 14, 2012 | clinicaltrials |
| NCT00714649 | Neoadjuvant Cetuximab in HNSCC Combined With Curative Surgery(CHIRON) | completed | Phase 1 / Phase 2 | 34 | Cliniques universitaires Saint-Luc- Université Catholique de LouvainOTHER | 1 | Nov 14, 2012 | clinicaltrials |
| NCT01280318 | Profile of Plasma Growth Factors Before and After Head and Neck Oncological or Non-oncological Surgery(HNSCC) | completed | Phase 1 / Phase 2 | 60 | Cliniques universitaires Saint-Luc- Université Catholique de LouvainOTHER | 1 | Nov 14, 2012 | clinicaltrials |
Data updated 23 days agoSource updated Feb 28, 2013source: clinicaltrials